Skip to main content
. 2022 Jun 10;14(12):2418. doi: 10.3390/nu14122418

Figure 1.

Figure 1

Acute administration with Gypenoside XVII decreased the immobility time but did not affect locomotor activity in the behavioral tests (n = 8). The structure of Gypenoside XVII and the experimental timeline (A). Open-field test (B,C). Tail suspension test (D). Forced swimming test (E). Serum corticosterone levels (F). * p < 0.05 and ** p < 0.01 versus the vehicle group.